Disclosures for "A Real-World Study of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder"
-
Ms. Gui has nothing to disclose.
-
Dr. Zhan has nothing to disclose.
-
Dr. lin has nothing to disclose.
-
Dr. li has nothing to disclose.
-
The institution of Prof. Bu has received research support from Beijing Huikang Charrity Foundation.